The Immune System – News and Features
News
Powerful Gene-Editing Tool Appears to Cause Off-Target Mutations in Human Cells
Results indicate need to improve precision of CRISPR-Cas RNA-guided nucleases.
News
Complix Raises €12 Million (US$15.5 million) in Series B Round
Financing to advance Alphabodies™, a unique class of protein therapeutics active against intracellular disease targets.
News
Forest Service Study Finds Urban Trees Removing Fine Particulate Air Pollution, Saving Lives
Scientists from U.S. Forest Service and the Davey Institute estimated how much fine particulate matter is removed by trees in 10 cities.
News
Absence of Gene Leads to Earlier, More Severe Case of Multiple Sclerosis
UCSF finding in animal study may lead to biomarker that predicts course of disease in humans.
News
XL-protein and GENERIUM Sign License and Collaboration Agreement
Agreement to develop PASylated therapeutics for the Russian Federation.
News
Transgene is to Acquire Immuno-Monitoring Activities of Indicia Biotechnology
Transaction will grow Platine Pharma Services’ business by 50%.
News
Alacrita and Debiopharm Group™ Collaborate
Collaboration to identify early stage drug candidates from the Massachusetts life science cluster.
News
Protalix BioTherapeutics Discloses Three New Compounds in Development
New biologics announced for treatment of immune mediated discorder, Cystic Fibrosis and emphysema.
News
What's New in the Diagnosis and Management of Food Allergy in Children?
With the increasing worldwide prevalence of food allergy comes a renewed impetus for improving diagnosis and management.
News
Molecular Farming Fits Need for Fully Functional Protein Therapeutics and Low-Cost Vaccines
Technology gains momentum through collaborations and licensing deals.
Advertisement
